Clinical Trial

The Impact of Daily Intake of Short-chain Fatty Acids on Cardiometabolic Risk Factors in Individuals at Risk for Metabolic Syndrome

Study acronym: 12OATS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 4, 2025 (before its estimated February 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
During this study, the effect of short-chain fatty acids on blood lipaedemia, glycemia, anthropometrics, blood pressure and energy expenditure will be investigated.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-22.
Trial Details
NCT Number NCT06951386
Lead Sponsor KU Leuven
Conditions Energy Expenditure, Metabolic Syndrome, Anthropometry, Body Composition, Glycemia, Lipaemia, Metabolomics, Blood Pressure
Enrollment 50 participants
Start Date 2025-02-11
Primary Completion 2026-02-28 (estimated)
Study Completion 2026-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-05-04